Tapewire

NYSE · USD

ICE

Intercontinental Exchange, Inc.

Export transactions ↓
Tapewire entity
1809
SEC CIK
0001571949
Parsed reports
941

Last 12 months

Inside the activity.

0 purchase rows · 64 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202505
Dec 202505
Jan 202600
Feb 2026026
Mar 202601
Apr 202600
May 202606
Jun 202602
Jul 202604
Aug 2026010
Sep 202605
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 15, 2022 Filed Feb 17, 2022 18:46 UTC
Wassersug MarkChief Operating Officer
GrantCommon Stock 8,582 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-010996 · doc4.xml · nonDerivative · entry 3

Wassersug Mark · CIK 0001722544 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,533

F3 · shares: Represents shares of performance based restricted stock units granted to the filing person on February 5, 2021. The vesting of the shares of performance based restricted stock units was conditioned upon the achievement of certain 2021 earnings before interest, taxes, depreciation, and amortization ("EBITDA") performance versus pre-established targets. The restricted stock units vest over three years (1/3 on February 15, 2022, 1/3 on February 15, 2023 and 1/3 on February 15, 2024). Of the 8,582 shares, 2,861 were issued on February 15, 2022, of which 1,291 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 5,721 shares are scheduled to be issued on the two remaining vesting dates and taxes for these future issuances will be withheld and reported at the time the shares are issued.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 18:43 UTC
Goone David SChief Strategic Officer
Tax withholdingCommon Stock 1,996 $125.22 $249,939.12
Disclosure

SEC source: 0001209191-22-010991 · doc4.xml · nonDerivative · entry 2

Goone David S · CIK 0001343869 · Chief Strategic Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 202,054

F2 · shares: Represents shares of common stock underlying vested restricted stock units that are being withheld to satisfy payment of the Issuer's tax withholding obligation.

F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 174,772 shares of common stock and 27,282 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2022 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023 and will be reported at the time of vesting. The satisfaction of the 2020, 2021 and 2022 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023, February 2024 and February 2025, respectively, and will be reported at the time of vesting.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 18:43 UTC
Goone David SChief Strategic Officer
GrantCommon Stock 13,486 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-010991 · doc4.xml · nonDerivative · entry 1

Goone David S · CIK 0001343869 · Chief Strategic Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 204,050

F1 · shares: Represents shares of performance based restricted stock units granted to the filing person on February 5, 2021. The vesting of the shares of performance based restricted stock units was conditioned upon the achievement of certain 2021 earnings before interest, taxes, depreciation, and amortization ("EBITDA") performance versus pre-established targets. The restricted stock units vest over three years (1/3 on February 15, 2022, 1/3 on February 15, 2023 and 1/3 on February 15, 2024). Of the 13,486 shares, 4,496 were issued on February 15, 2022, of which 1,996 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 8,990 shares are scheduled to be issued on the two remaining vesting dates and taxes for these future issuances will be withheld and reported at the time the shares are issued.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 18:48 UTC
Sprecher Jeffrey CDirector · Chief Executive Officer
Tax withholdingCommon Stock 8,000 $125.22 $1,001,760.00
Disclosure

SEC source: 0001209191-22-011000 · doc4.xml · nonDerivative · entry 2

Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,306,223

F3 · shares: Represents shares of common stock underlying vested restricted stock units that are being withheld to satisfy payment of the Issuer's tax withholding obligation.

F4 · balance_after: The common stock number referred in Table I is an aggregate number and represents 1,199,566 shares of common stock and 106,657 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2022 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023 and will be reported at the time of vesting. The satisfaction of the 2020, 2021 and 2022 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023, February 2024 and February 2025, respectively, and will be reported at the time of vesting.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 18:48 UTC
Sprecher Jeffrey CDirector · Chief Executive Officer
GrantCommon Stock 52,718 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-011000 · doc4.xml · nonDerivative · entry 1

Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,314,223

F1 · shares: Represents shares of performance based restricted stock units granted to the filing person on February 5, 2021. The vesting of the shares of performance based restricted stock units was conditioned upon the achievement of certain 2021 earnings before interest, taxes, depreciation, and amortization ("EBITDA") performance versus pre-established targets. The restricted stock units vest over three years (1/3 on February 15, 2022, 1/3 on February 15, 2023 and 1/3 on February 15, 2024). Of the 52,718 shares, 17,573 were issued on February 15, 2022, of which 8,000 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 35,145 shares are scheduled to be issued on the two remaining vesting dates and taxes for these future issuances will be withheld and reported at the time the shares are issued.

F2 · balance_after: Amount of securities beneficially owned includes 105 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on December 31, 2021.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 23:48 UTC
Surdykowski Andrew JGeneral Counsel
Tax withholdingCommon Stock 781 $125.22 $97,796.82
Disclosure

SEC source: 0001209191-22-011001 · doc4.xml · nonDerivative · entry 2

Surdykowski Andrew J · CIK 0001755922 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,102

F3 · shares: Represents shares of common stock underlying vested restricted stock units that are being withheld to satisfy payment of the Issuer's tax withholding obligation.

F4 · balance_after: The common stock number referred in Table I is an aggregate number and represents 33,365 shares of common stock and 10,737 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2022 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023 and will be reported at the time of vesting. The satisfaction of the 2020, 2021 and 2022 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023, February 2024 and February 2025, respectively, and will be reported at the time of vesting.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 23:48 UTC
Surdykowski Andrew JGeneral Counsel
GrantCommon Stock 6,129 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-011001 · doc4.xml · nonDerivative · entry 1

Surdykowski Andrew J · CIK 0001755922 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,883

F1 · shares: Represents shares of performance based restricted stock units granted to the filing person on February 5, 2021. The vesting of the shares of performance based restricted stock units was conditioned upon the achievement of certain 2021 earnings before interest, taxes, depreciation, and amortization ("EBITDA") performance versus pre-established targets. The restricted stock units vest over three years (1/3 on February 15, 2022, 1/3 on February 15, 2023 and 1/3 on February 15, 2024). Of the 6,129 shares, 2,043 were issued on February 15, 2022, of which 781 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 4,086 shares are scheduled to be issued on the two remaining vesting dates and taxes for these future issuances will be withheld and reported at the time the shares are issued.

F2 · balance_after: Amount of securities beneficially owned includes 105 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on December 31, 2021.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 23:45 UTC
Martin Lynn CPresident, NYSE Group
Tax withholdingCommon Stock 2,296 $125.22 $287,505.12
Disclosure

SEC source: 0001209191-22-010995 · doc4.xml · nonDerivative · entry 2

Martin Lynn C · CIK 0001754817 · President, NYSE Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,524

F3 · shares: Represents shares of common stock underlying vested restricted stock units that are being withheld to satisfy payment of the Issuer's tax withholding obligation.

F4 · balance_after: The common stock number referred in Table I is an aggregate number and represents 22,419 shares of common stock, 3,840 unvested restricted stock units ("RSUs"), and 21,265 unvested performance based restricted stock units ("PSU's"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2022 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023 and will be reported at the time of vesting. The satisfaction of the 2020, 2021 and 2022 total shareholder return PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023, February 2024 and February 2025, respectively, and will be reported at the time of vesting.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 23:45 UTC
Martin Lynn CPresident, NYSE Group
GrantCommon Stock 13,486 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-010995 · doc4.xml · nonDerivative · entry 1

Martin Lynn C · CIK 0001754817 · President, NYSE Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,820

F1 · shares: Represents shares of performance based restricted stock units granted to the filing person on February 5, 2021. The vesting of the shares of performance based restricted stock units was conditioned upon the achievement of certain 2021 earnings before interest, taxes, depreciation, and amortization ("EBITDA") performance versus pre-established targets. The restricted stock units vest over three years (1/3 on February 15, 2022, 1/3 on February 15, 2023 and 1/3 on February 15, 2024). Of the 13,486 shares, 4,496 were issued on February 15, 2022, of which 2,296 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 8,990 shares are scheduled to be issued on the two remaining vesting dates and taxes for these future issuances will be withheld and reported at the time the shares are issued.

F2 · balance_after: Amount of securities beneficially owned includes 105 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on December 31, 2021.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 23:44 UTC Tax withholdingCommon Stock 2,774 $125.22 $347,360.28
Disclosure

SEC source: 0001209191-22-010993 · doc4.xml · nonDerivative · entry 2

Jackson Benjamin · CIK 0001722067 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 115,304

F3 · shares: Represents shares of common stock underlying vested restricted stock units that are being withheld to satisfy payment of the Issuer's tax withholding obligation.

F4 · balance_after: The common stock number referred in Table I is an aggregate number and represents 84,752 shares of common stock and 30,552 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2022 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023 and will be reported at the time of vesting. The satisfaction of the 2020, 2021 and 2022 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023, February 2024 and February 2025, respectively, and will be reported at the time of vesting.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 23:44 UTC GrantCommon Stock 18,390 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-010993 · doc4.xml · nonDerivative · entry 1

Jackson Benjamin · CIK 0001722067 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 118,078

F1 · shares: Represents shares of performance based restricted stock units granted to the filing person on February 5, 2021. The vesting of the shares of performance based restricted stock units was conditioned upon the achievement of certain 2021 earnings before interest, taxes, depreciation, and amortization ("EBITDA") performance versus pre-established targets. The restricted stock units vest over three years (1/3 on February 15, 2022, 1/3 on February 15, 2023 and 1/3 on February 15, 2024). Of the 18,390 shares, 6,130 were issued on February 15, 2022, of which 2,774 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 12,260 shares are scheduled to be issued on the two remaining vesting dates and taxes for these future issuances will be withheld and reported at the time the shares are issued.

F2 · balance_after: Amount of securities beneficially owned includes 105 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on December 31, 2021.

Read SEC document
February 10, 2022 Filed Feb 17, 2022 18:46 UTC
Wassersug MarkChief Operating Officer
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative 11,022 $0.00 Strike: $50.01 $0.00
Disclosure

SEC source: 0001209191-22-010996 · doc4.xml · derivative · entry 5

Wassersug Mark · CIK 0001722544 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,958

Underlying: Common Stock · 11,022 shares

Expires 2026-01-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: These options are fully vested.

Read SEC document
February 10, 2022 Filed Feb 17, 2022 18:46 UTC
Wassersug MarkChief Operating Officer
SaleCommon Stock 11,022 $127.00 $1,399,794.00
Disclosure

SEC source: 0001209191-22-010996 · doc4.xml · nonDerivative · entry 2

Wassersug Mark · CIK 0001722544 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,951

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

Read SEC document
February 10, 2022 Filed Feb 17, 2022 18:46 UTC
Wassersug MarkChief Operating Officer
Exercise / conversionCommon Stock 11,022 $50.01 $551,210.22
Disclosure

SEC source: 0001209191-22-010996 · doc4.xml · nonDerivative · entry 1

Wassersug Mark · CIK 0001722544 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,973

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F2 · balance_after: Amount of securities beneficially owned includes 105 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on December 31, 2021.

Read SEC document
February 09, 2022 Filed Feb 10, 2022 21:49 UTC SaleCommon Stock 894 $130.36 $116,543.27
Disclosure

SEC source: 0001209191-22-008511 · doc4.xml · nonDerivative · entry 2

CRISP CHARLES R · CIK 0001015825 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,475

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F3 · price: The price range for the aggregate amount sold by the direct holder is $129.96 - $130.70. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

F4 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 33,754 shares of common stock and 1,721 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 14, 2022.

Read SEC document
February 09, 2022 Filed Feb 10, 2022 21:49 UTC SaleCommon Stock 2,233 $129.44 $289,037.51
Disclosure

SEC source: 0001209191-22-008511 · doc4.xml · nonDerivative · entry 1

CRISP CHARLES R · CIK 0001015825 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,369

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F2 · price: The price range for the aggregate amount sold by the direct holder is $128.95 - $129.85. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

Read SEC document
February 08, 2022 Filed Feb 10, 2022 16:50 UTC
Namkung James WChief Accounting Officer
Tax withholdingCommon Stock 165 $127.59 $21,052.35
Disclosure

SEC source: 0001209191-22-008514 · doc4.xml · nonDerivative · entry 1

Namkung James W · CIK 0001729468 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,456

F1 · shares: Represents shares of restricted stock issued to the filing person on February 8, 2019. The restricted stock units vest over three years (1/3 on February 8, 2020, 1/3 on February 8, 2021 and 1/3 on February 8, 2022). Of the 1,641 shares, the remaining 547 shares were issued on February 8, 2022, of which 165 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The third and final tranche of shares for this award have been issued.

F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 9,142 shares of common stock and 1,326 unvested restricted stock units ("RSUs"), and 4,988 unvested performance based restricted stock units ("PSU's"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2022 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023 and will be reported at the time of vesting. The satisfaction of the 2022 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2025 and will be reported at the time of vesting.

Read SEC document
February 08, 2022 Filed Feb 11, 2022 23:31 UTC
Gardiner WarrenChief Financial Officer
Tax withholdingCommon Stock 133 $127.59 $16,969.47
Disclosure

SEC source: 0001209191-22-008995 · doc4.xml · nonDerivative · entry 3

Gardiner Warren · CIK 0001855007 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,748

F3 · shares: Represents shares of restricted stock issued to the filing person on February 8, 2019. The restricted stock units vest over three years (1/3 on February 8, 2020, 1/3 on February 8, 2021 and 1/3 on February 8, 2022). Of the 1,313 shares, the remaining 438 shares were issued on February 8, 2022, of which 133 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The third and final tranche of shares for this award have been issued.

F4 · balance_after: The common stock number referred in Table I is an aggregate number and represents 6,023 shares of common stock and 3,355 unvested restricted stock units ("RSUs"), and 5,370 unvested performance based restricted stock units ("PSU's"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2022 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023 and will be reported at the time of vesting. The satisfaction of the 2022 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2025 and will be reported at the time of vesting.

Read SEC document
February 07, 2022 Filed Feb 9, 2022 17:18 UTC
Namkung James WChief Accounting Officer
Tax withholdingCommon Stock 132 $127.68 $16,853.76
Disclosure

SEC source: 0001209191-22-008112 · doc4.xml · nonDerivative · entry 2

Namkung James W · CIK 0001729468 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,621

F3 · shares: Represents shares of restricted stock issued to the filing person on February 5, 2021. The restricted stock units vest over three years (1/3 on February 5, 2022, 1/3 on February 5, 2023 and 1/3 on February 5, 2024). Of the 1,313 shares, 437 shares were issued on February 7, 2022, of which 132 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 876 shares are scheduled to be issued on the two remaining vesting dates and taxes for these future issuances will be withheld and reported at the time the shares are issued.

F4 · balance_after: The common stock number referred in Table I is an aggregate number and represents 8,760 shares of common stock and 1,873 unvested restricted stock units ("RSUs"), and 4,988 unvested performance based restricted stock units ("PSU's"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2022 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023 and will be reported at the time of vesting. The satisfaction of the 2022 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2025 and will be reported at the time of vesting.

Read SEC document
February 07, 2022 Filed Feb 9, 2022 17:18 UTC
Namkung James WChief Accounting Officer
Tax withholdingCommon Stock 136 $127.68 $17,364.48
Disclosure

SEC source: 0001209191-22-008112 · doc4.xml · nonDerivative · entry 1

Namkung James W · CIK 0001729468 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,753

F1 · shares: Represents shares of restricted stock issued to the filing person on February 7, 2020. The restricted stock units vest over three years (1/3 on February 7, 2021, 1/3 on February 7, 2022 and 1/3 on February 7, 2023). Of the 1,349 shares, 450 shares were issued on February 7, 2022, of which 136 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 450 shares are scheduled to be issued on February 7, 2023 and taxes for this issuance will be withheld and reported at the time of vesting.

F2 · balance_after: Amount of securities beneficially owned includes 105 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on December 31, 2021.

Read SEC document
February 07, 2022 Filed Feb 11, 2022 23:31 UTC
Gardiner WarrenChief Financial Officer
Tax withholdingCommon Stock 133 $127.68 $16,981.44
Disclosure

SEC source: 0001209191-22-008995 · doc4.xml · nonDerivative · entry 2

Gardiner Warren · CIK 0001855007 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,881

F2 · shares: Represents shares of restricted stock issued to the filing person on February 5, 2021. The restricted stock units vest over three years (1/3 on February 5, 2022, 1/3 on February 5, 2023 and 1/3 on February 5, 2024). Of the 1,313 shares, 437 shares were issued on February 7, 2022, of which 133 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 876 shares are scheduled to be issued on the two remaining vesting dates and taxes for these future issuances will be withheld and reported at the time the shares are issued.

Read SEC document
February 07, 2022 Filed Feb 11, 2022 23:31 UTC
Gardiner WarrenChief Financial Officer
Tax withholdingCommon Stock 136 $127.68 $17,364.48
Disclosure

SEC source: 0001209191-22-008995 · doc4.xml · nonDerivative · entry 1

Gardiner Warren · CIK 0001855007 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,014

F1 · shares: Represents shares of restricted stock issued to the filing person on February 7, 2020. The restricted stock units vest over three years (1/3 on February 7, 2021, 1/3 on February 7, 2022 and 1/3 on February 7, 2023). Of the 1,349 shares, 450 shares were issued on February 7, 2022, of which 136 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 450 shares are scheduled to be issued on February 7, 2023 and taxes for this issuance will be withheld and reported at the time of vesting.

Read SEC document
February 04, 2022 Filed Feb 8, 2022 21:35 UTC
Gardiner WarrenChief Financial Officer
GrantEmployee Stock Option (right to buy) Holding · Derivative 8,869 $0.00 Strike: $129.76 $0.00
Disclosure

SEC source: 0001209191-22-007759 · doc4.xml · derivative · entry 1

Gardiner Warren · CIK 0001855007 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,869

Underlying: Common Stock · 8,869 shares

Expires 2032-02-04

F1 · derivative.exercise_date: These options vest in accordance with the following schedule: 33.33% of the options vest on February 4, 2023, 33.33% of the options vest on February 4, 2024 and 33.33% of the options vest on February 4, 2025.

Read SEC document
February 04, 2022 Filed Feb 8, 2022 16:40 UTC
Namkung James WChief Accounting Officer
GrantEmployee Stock Option (right to buy) Holding · Derivative 4,257 $0.00 Strike: $129.76 $0.00
Disclosure

SEC source: 0001209191-22-007764 · doc4.xml · derivative · entry 1

Namkung James W · CIK 0001729468 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,257

Underlying: Common Stock · 4,257 shares

Expires 2032-02-04

F1 · derivative.exercise_date: These options vest in accordance with the following schedule: 33.33% of the options vest on February 4, 2023, 33.33% of the options vest on February 4, 2024 and 33.33% of the options vest on February 4, 2025.

Read SEC document
February 04, 2022 Filed Feb 8, 2022 16:43 UTC
Wassersug MarkChief Operating Officer
GrantEmployee Stock Option (right to buy) Holding · Derivative 13,482 $0.00 Strike: $129.76 $0.00
Disclosure

SEC source: 0001209191-22-007770 · doc4.xml · derivative · entry 1

Wassersug Mark · CIK 0001722544 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,482

Underlying: Common Stock · 13,482 shares

Expires 2032-02-04

F1 · derivative.exercise_date: These options vest in accordance with the following schedule: 33.33% of the options vest on February 4, 2023, 33.33% of the options vest on February 4, 2024 and 33.33% of the options vest on February 4, 2025.

Read SEC document
February 04, 2022 Filed Feb 8, 2022 16:37 UTC
Goone David SChief Strategic Officer
GrantEmployee Stock Option (right to buy) Holding · Derivative 19,513 $0.00 Strike: $129.76 $0.00
Disclosure

SEC source: 0001209191-22-007760 · doc4.xml · derivative · entry 1

Goone David S · CIK 0001343869 · Chief Strategic Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,513

Underlying: Common Stock · 19,513 shares

Expires 2032-02-04

F1 · derivative.exercise_date: These options vest in accordance with the following schedule: 33.33% of the options vest on February 4, 2023, 33.33% of the options vest on February 4, 2024 and 33.33% of the options vest on February 4, 2025.

Read SEC document
February 04, 2022 Filed Feb 8, 2022 16:41 UTC
Sprecher Jeffrey CDirector · Chief Executive Officer
GrantEmployee Stock Option (right to buy) Holding · Derivative 88,699 $0.00 Strike: $129.76 $0.00
Disclosure

SEC source: 0001209191-22-007765 · doc4.xml · derivative · entry 1

Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,699

Underlying: Common Stock · 88,699 shares

Expires 2032-02-04

F1 · derivative.exercise_date: These options vest in accordance with the following schedule: 33.33% of the options vest on February 4, 2023, 33.33% of the options vest on February 4, 2024 and 33.33% of the options vest on February 4, 2025.

Read SEC document
February 04, 2022 Filed Feb 8, 2022 21:42 UTC
Surdykowski Andrew JGeneral Counsel
GrantEmployee Stock Option (right to buy) Holding · Derivative 10,643 $0.00 Strike: $129.76 $0.00
Disclosure

SEC source: 0001209191-22-007768 · doc4.xml · derivative · entry 1

Surdykowski Andrew J · CIK 0001755922 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,643

Underlying: Common Stock · 10,643 shares

Expires 2032-02-04

F1 · derivative.exercise_date: These options vest in accordance with the following schedule: 33.33% of the options vest on February 4, 2023, 33.33% of the options vest on February 4, 2024 and 33.33% of the options vest on February 4, 2025.

Read SEC document
February 04, 2022 Filed Feb 8, 2022 21:39 UTC
Martin Lynn CPresident, NYSE Group
GrantEmployee Stock Option (right to buy) Holding · Derivative 19,513 $0.00 Strike: $129.76 $0.00
Disclosure

SEC source: 0001209191-22-007763 · doc4.xml · derivative · entry 1

Martin Lynn C · CIK 0001754817 · President, NYSE Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,513

Underlying: Common Stock · 19,513 shares

Expires 2032-02-04

F1 · derivative.exercise_date: These options vest in accordance with the following schedule: 33.33% of the options vest on February 4, 2023, 33.33% of the options vest on February 4, 2024 and 33.33% of the options vest on February 4, 2025.

Read SEC document
February 04, 2022 Filed Feb 8, 2022 21:38 UTC GrantEmployee Stock Option (right to buy) Holding · Derivative 26,609 $0.00 Strike: $129.76 $0.00
Disclosure

SEC source: 0001209191-22-007761 · doc4.xml · derivative · entry 1

Jackson Benjamin · CIK 0001722067 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,609

Underlying: Common Stock · 26,609 shares

Expires 2032-02-04

F1 · derivative.exercise_date: These options vest in accordance with the following schedule: 33.33% of the options vest on February 4, 2023, 33.33% of the options vest on February 4, 2024 and 33.33% of the options vest on February 4, 2025.

Read SEC document
December 10, 2021 Filed Dec 10, 2021 16:34 UTC
Wassersug MarkChief Operating Officer
SaleCommon Stock 1,072 $135.20 $144,934.40
Disclosure

SEC source: 0001209191-21-069056 · doc4.xml · nonDerivative · entry 1

Wassersug Mark · CIK 0001722544 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,846

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 9,379 shares of common stock and 9,467 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2021 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022 and will be reported at the time of vesting. The satisfaction of the 2019, 2020 and 2021 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022, February 2023 and February 2024, respectively, and will be reported at the time of vesting.

Read SEC document
December 09, 2021 Filed Dec 10, 2021 16:34 UTC
Sprecher Jeffrey CDirector · Chief Executive Officer
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative 2,400 $0.00 Strike: $41.59 $0.00
Disclosure

SEC source: 0001209191-21-069054 · doc4.xml · derivative · entry 5

Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 211,325

Underlying: Common Stock · 2,400 shares

Expires 2025-01-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: These options are fully vested.

Read SEC document
December 09, 2021 Filed Dec 10, 2021 16:34 UTC
Sprecher Jeffrey CDirector · Chief Executive Officer
SaleCommon Stock 14,175 $135.12 $1,915,310.41
Disclosure

SEC source: 0001209191-21-069054 · doc4.xml · nonDerivative · entry 3

Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · CPEX

Disclosed balance after: 3,031,705

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F4 · price: The price range for the aggregate amount sold by the direct holder is $134.95 - $135.40. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

F5 · balance_after: These shares are beneficially owned directly by Continental Power Exchange, Inc. ("CPEX"). Mr. Sprecher beneficially owns 100% of the equity interest in CPEX directly.

Read SEC document
December 09, 2021 Filed Dec 10, 2021 16:34 UTC
Sprecher Jeffrey CDirector · Chief Executive Officer
SaleCommon Stock 45,825 $134.63 $6,169,488.49
Disclosure

SEC source: 0001209191-21-069054 · doc4.xml · nonDerivative · entry 2

Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · CPEX

Disclosed balance after: 3,045,880

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F3 · price: The price range for the aggregate amount sold by the direct holder is $133.95 - $134.94. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

Read SEC document
December 09, 2021 Filed Dec 10, 2021 16:34 UTC
Sprecher Jeffrey CDirector · Chief Executive Officer
Exercise / conversionCommon Stock 2,400 $41.59 $99,816.00
Disclosure

SEC source: 0001209191-21-069054 · doc4.xml · nonDerivative · entry 1

Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,261,400

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 1,189,888 shares of common stock and 71,512 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2021 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022 and will be reported at the time of vesting. The satisfaction of the 2019, 2020 and 2021 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022, February 2023 and February 2024, respectively, and will be reported at the time of vesting.

Read SEC document
December 06, 2021 Filed Dec 8, 2021 17:12 UTC
Goone David SChief Strategic Officer
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative 1,492 $0.00 Strike: $67.00 $0.00
Disclosure

SEC source: 0001209191-21-068547 · doc4.xml · derivative · entry 2

Goone David S · CIK 0001343869 · Chief Strategic Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,849

Underlying: Common Stock · 1,492 shares

Expires 2028-02-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: These options are fully vested.

Read SEC document
December 06, 2021 Filed Dec 8, 2021 17:12 UTC
Goone David SChief Strategic Officer
Exercise / conversionCommon Stock 1,492 $67.00 $99,964.00
Disclosure

SEC source: 0001209191-21-068547 · doc4.xml · nonDerivative · entry 1

Goone David S · CIK 0001343869 · Chief Strategic Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 190,564

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: The common stock number referred in Table I is an aggregate number and represents 172,272 shares of common stock and 18,292 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2021 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022 and will be reported at the time of vesting. The satisfaction of the 2019, 2020 and 2021 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022, February 2023 and February 2024, respectively, and will be reported at the time of vesting.

Read SEC document
December 03, 2021 Filed Dec 7, 2021 21:34 UTC
Martin Lynn CPresident, Fixed Income & Data
GrantCommon Stock 3,840 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-068322 · doc4.xml · nonDerivative · entry 1

Martin Lynn C · CIK 0001754817 · President, Fixed Income & Data

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,229

F1 · shares: Represents shares of restricted stock issued to the filing person on December 3, 2021. This award of restricted stock vests over three years (1/3 on each anniversary of the award date).

F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 20,114 shares of common stock, 3,840 unvested restricted stock units ("RSUs"), and 12,275 unvested performance based restricted stock units ("PSU's"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2021 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022 and will be reported at the time of vesting. The satisfaction of the 2019, 2020 and 2021 total shareholder return PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022, February 2023 and February 2024, respectively, and will be reported at the time of vesting.

Read SEC document
November 23, 2021 Filed Nov 26, 2021 16:31 UTC
Sprecher Jeffrey CDirector · Chief Executive Officer
GiftCommon Stock 67,500 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-066932 · doc4.xml · nonDerivative · entry 1

Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,259,000

F1 · shares: This transaction involved a gift of 67,500 shares of the Issuer's common stock by the reporting person to a philanthropic organization.

F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 1,187,488 shares of common stock and 71,512 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2021 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022 and will be reported at the time of vesting. The satisfaction of the 2019, 2020 and 2021 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022, February 2023 and February 2024, respectively, and will be reported at the time of vesting.

Read SEC document
November 10, 2021 Filed Nov 12, 2021 21:32 UTC
Gardiner WarrenChief Financial Officer
SaleCommon Stock 1,300 $135.08 $175,604.00
Disclosure

SEC source: 0001209191-21-064200 · doc4.xml · nonDerivative · entry 1

Gardiner Warren · CIK 0001855007 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,150

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 5,100 shares of common stock and 4,680 unvested restricted stock units ("RSUs"), and 5,370 unvested performance based restricted stock units ("PSU's"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2021 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022 and will be reported at the time of vesting.

Read SEC document
November 10, 2021 Filed Nov 12, 2021 16:33 UTC
Wassersug MarkChief Operating Officer
SaleCommon Stock 2,000 $135.08 $270,160.00
Disclosure

SEC source: 0001209191-21-064203 · doc4.xml · nonDerivative · entry 1

Wassersug Mark · CIK 0001722544 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,918

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 10,451 shares of common stock and 9,467 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2021 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022 and will be reported at the time of vesting. The satisfaction of the 2019, 2020 and 2021 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022, February 2023 and February 2024, respectively, and will be reported at the time of vesting.

Read SEC document
November 10, 2021 Filed Nov 12, 2021 21:33 UTC
Surdykowski Andrew JGeneral Counsel
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative 2,070 $0.00 Strike: $50.01 $0.00
Disclosure

SEC source: 0001209191-21-064201 · doc4.xml · derivative · entry 5

Surdykowski Andrew J · CIK 0001755922 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,580

Underlying: Common Stock · 2,070 shares

Expires 2026-01-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options are fully vested.

Read SEC document
November 10, 2021 Filed Nov 12, 2021 21:33 UTC
Surdykowski Andrew JGeneral Counsel
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative 2,500 $0.00 Strike: $41.59 $0.00
Disclosure

SEC source: 0001209191-21-064201 · doc4.xml · derivative · entry 4

Surdykowski Andrew J · CIK 0001755922 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,500

Underlying: Common Stock · 2,500 shares

Expires 2025-01-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options are fully vested.

Read SEC document
November 10, 2021 Filed Nov 12, 2021 21:33 UTC
Surdykowski Andrew JGeneral Counsel
SaleCommon Stock 4,500 $135.08 $607,860.00
Disclosure

SEC source: 0001209191-21-064201 · doc4.xml · nonDerivative · entry 3

Surdykowski Andrew J · CIK 0001755922 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,649

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 31,998 shares of common stock and 6,651 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2021 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022 and will be reported at the time of vesting. The satisfaction of the 2019, 2020 and 2021 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022, February 2023 and February 2024, respectively, and will be reported at the time of vesting.

Read SEC document
November 10, 2021 Filed Nov 12, 2021 21:33 UTC
Surdykowski Andrew JGeneral Counsel
Exercise / conversionCommon Stock 2,070 $50.01 $103,520.70
Disclosure

SEC source: 0001209191-21-064201 · doc4.xml · nonDerivative · entry 2

Surdykowski Andrew J · CIK 0001755922 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,149

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

Read SEC document
November 10, 2021 Filed Nov 12, 2021 21:33 UTC
Surdykowski Andrew JGeneral Counsel
Exercise / conversionCommon Stock 2,500 $41.59 $103,975.00
Disclosure

SEC source: 0001209191-21-064201 · doc4.xml · nonDerivative · entry 1

Surdykowski Andrew J · CIK 0001755922 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,079

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

Read SEC document
November 08, 2021 Filed Nov 10, 2021 21:32 UTC Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative 2,770 $0.00 Strike: $41.37 $0.00
Disclosure

SEC source: 0001209191-21-063860 · doc4.xml · derivative · entry 2

Jackson Benjamin · CIK 0001722067 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,100

Underlying: Common Stock · 2,770 shares

Expires 2024-01-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: These options are fully vested.

Read SEC document
November 08, 2021 Filed Nov 10, 2021 21:32 UTC Exercise / conversionCommon Stock 2,770 $41.37 $114,594.90
Disclosure

SEC source: 0001209191-21-063860 · doc4.xml · nonDerivative · entry 1

Jackson Benjamin · CIK 0001722067 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 99,583

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F2 · balance_after: Amount of securities beneficially owned includes 110 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2021.

F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 81,291 shares of common stock and 18,292 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2021 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022 and will be reported at the time of vesting. The satisfaction of the 2019, 2020 and 2021 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022, February 2023 and February 2024, respectively, and will be reported at the time of vesting.

Read SEC document
October 29, 2021 Filed Nov 2, 2021 16:31 UTC
Namkung James WChief Accounting Officer
SaleCommon Stock 1,559 $135.09 $210,605.31
Disclosure

SEC source: 0001209191-21-062413 · doc4.xml · nonDerivative · entry 1

Namkung James W · CIK 0001729468 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,784

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 8,036 shares of common stock and 2,760 unvested restricted stock units ("RSUs"), and 4,988 unvested performance based restricted stock units ("PSU's"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2021 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2022 and will be reported at the time of vesting.

Read SEC document
October 29, 2021 Filed Nov 2, 2021 20:30 UTC SaleCommon Stock 1,979 $135.09 $267,343.11
Disclosure

SEC source: 0001209191-21-062410 · doc4.xml · nonDerivative · entry 1

Farooqui Duriya M · CIK 0001699994 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,393

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F2 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 7,672 shares of common stock and 1,721 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 14, 2022.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.